CN1283106A - 含有具有亲脂性糖皮质甾类和唯一一种表面活性剂的胶束的药物组合物 - Google Patents

含有具有亲脂性糖皮质甾类和唯一一种表面活性剂的胶束的药物组合物 Download PDF

Info

Publication number
CN1283106A
CN1283106A CN98812507A CN98812507A CN1283106A CN 1283106 A CN1283106 A CN 1283106A CN 98812507 A CN98812507 A CN 98812507A CN 98812507 A CN98812507 A CN 98812507A CN 1283106 A CN1283106 A CN 1283106A
Authority
CN
China
Prior art keywords
glucocorticosteroid
compositions
surfactant
medicine
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98812507A
Other languages
English (en)
Chinese (zh)
Inventor
G·舍奎斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1283106A publication Critical patent/CN1283106A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN98812507A 1997-12-22 1998-12-22 含有具有亲脂性糖皮质甾类和唯一一种表面活性剂的胶束的药物组合物 Pending CN1283106A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE97048334 1997-12-22
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation

Publications (1)

Publication Number Publication Date
CN1283106A true CN1283106A (zh) 2001-02-07

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98812507A Pending CN1283106A (zh) 1997-12-22 1998-12-22 含有具有亲脂性糖皮质甾类和唯一一种表面活性剂的胶束的药物组合物

Country Status (20)

Country Link
EP (1) EP1043973A1 (no)
JP (1) JP2001526210A (no)
KR (1) KR20010024789A (no)
CN (1) CN1283106A (no)
AR (1) AR017220A1 (no)
AU (1) AU1993599A (no)
BR (1) BR9813811A (no)
CA (1) CA2315782A1 (no)
EE (1) EE200000388A (no)
HU (1) HUP0102365A3 (no)
ID (1) ID26945A (no)
IL (1) IL136880A0 (no)
NO (1) NO20003220L (no)
NZ (1) NZ505073A (no)
PL (1) PL341361A1 (no)
SE (1) SE9704833D0 (no)
SK (1) SK9532000A3 (no)
TR (1) TR200001977T2 (no)
WO (1) WO1999032089A1 (no)
ZA (1) ZA9811461B (no)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
CN101982168A (zh) * 2010-11-02 2011-03-02 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678A (zh) * 2011-05-26 2012-11-28 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JPWO2005018607A1 (ja) * 2003-08-20 2007-11-01 味の素株式会社 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090123390A1 (en) 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
AU2008321396A1 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
EP2334285A1 (en) * 2008-09-12 2011-06-22 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
CA2917921C (en) * 2013-07-17 2021-08-03 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
CN101982168A (zh) * 2010-11-02 2011-03-02 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678A (zh) * 2011-05-26 2012-11-28 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法

Also Published As

Publication number Publication date
HUP0102365A3 (en) 2002-01-28
IL136880A0 (en) 2001-06-14
WO1999032089A1 (en) 1999-07-01
HUP0102365A2 (hu) 2001-11-28
EP1043973A1 (en) 2000-10-18
BR9813811A (pt) 2000-10-03
JP2001526210A (ja) 2001-12-18
AU1993599A (en) 1999-07-12
NO20003220L (no) 2000-08-22
ID26945A (id) 2001-02-22
NZ505073A (en) 2002-09-27
SE9704833D0 (sv) 1997-12-22
SK9532000A3 (en) 2000-11-07
CA2315782A1 (en) 1999-07-01
AR017220A1 (es) 2001-08-22
NO20003220D0 (no) 2000-06-21
EE200000388A (et) 2002-02-15
KR20010024789A (ko) 2001-03-26
TR200001977T2 (tr) 2000-12-21
ZA9811461B (en) 1999-06-22
PL341361A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
CN1283106A (zh) 含有具有亲脂性糖皮质甾类和唯一一种表面活性剂的胶束的药物组合物
JP6966981B2 (ja) ステロイドの抗痙攣活性
AU2006233604B2 (en) Pharmaceutical aerosol composition
JP4875239B2 (ja) 鼻および肺送達のためのコルチコステロイドを含有する水性組成物
US8455002B2 (en) Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
TW537903B (en) New stable pharmaceutical preparation for producing propellant gas-free aerosols
US20050244339A1 (en) Pharmaceutical aerosol composition
JP2006523630A (ja) 鼻用医薬製剤およびその使用方法
US20120022032A1 (en) Corticosteroid compositions and methods of treatments thereof
EA012388B1 (ru) Водные суспензии циклесонида для аэрозольного распыления
CN101757625A (zh) 环糊精包合皮质激素和h1受体拮抗剂的鼻用药物组合物
JP2010538081A (ja) Ｄｈｅａｓ吸入組成物
WO2020129085A1 (en) Intranasal formulation
JPH08151332A (ja) 点鼻用水性懸濁液
WO2015009776A1 (en) Low dose corticosteroid microemulsion compositions and methods of treatments thereof
MXPA00006161A (en) Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant
US20240091216A1 (en) Liquid formulations of indacaterol
CZ20002298A3 (cs) Farmaceutický prostředek, obsahující micely ve vodném prostředí, a způsob jeho přípravy
KR20180030399A (ko) 네뷸라이저용 조성물
WO2023192445A1 (en) Liquid formulations of indacaterol and glycopyrronium
BR112020015646A2 (pt) Formulações intranasais de epinefrina e métodos para o tratamento de doença
CN1750810A (zh) 低剂量皮质类固醇组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication